Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 38 |
| Active Pipeline (Recruiting Now) | 14 (10) |
| Completed vs Stopped Early | 17 / 5 (13.2%) |
| Median Closed Actual Enrollment | 87 participants |
| Physical Hospital Site Disclosure | 2.1% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Explore interactive annual charts and M&A subsidiary rollups in the Vanda Pharmaceuticals Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.